title: Two-dimensional 13C-1H heteronuclear correlation NMR spectroscopic studies for the inclusion complex of cyclomaltoheptaose (beta-cyclodextrin) with a new Helicobacter pylori eradicating agent (TG44) in the amorphous state.
abstract: The interaction of a newly developed Helicobacter pylori eradicating agent (TG44, 4-methylbenzyl-4'-[trans-4-(guanidinomethyl)cyclohexylcarbonyloxy]-biphenyl-4-carboxlylate monohydrochloride) with cyclomaltoheptaose (beta-cyclodextrin, beta-CyD) in the solid state was studied by high-speed frequency-switched Lee-Goldburg (FSLG) (13)C-(1)H heteronuclear correlation (HETCOR) NMR experiments. The TG44/beta-CyD solid complex in a 1:1 stoichiometry was prepared by the grinding method. Powder X-ray diffractometry confirmed that the complex is in an amorphous state. The solid-state (13)C signals of TG44 and beta-CyD were significantly broadened by the complexation. As the temperature increased, the (13)C signals of the aromatic moieties of TG44 were insignificantly influenced, whereas those of the cyclohexyl moiety became sharper. The T1(rho) H values of the aromatic moieties of TG44 were almost the same as those of the beta-CyD carbons, whereas those of other TG44 carbons gave much smaller values. The (13)C-(1)H HETCOR spectra gave the intermolecular correlation peaks between the aromatic carbons of TG44 and the beta-CyD protons or between the biphenyl protons of TG44 and the beta-CyD carbons, when measured using longer contact times (500 and 1500mus). On the basis of these solid NMR spectroscopic data together with aqueous NMR data, we assume that beta-CyD includes predominantly the biphenyl moiety of TG44 in the solid state. (13)C-(1)H HETCOR spectroscopy is particularly useful for the determination of inclusion modes of the complexes that occurring in an amorphous form.
authors.affiliation: Nagase ChemteX Corporation, Kobe Product Development Center, 2-2-3 Murotani, Nishi-ku, Kobe, Hyogo 651-2241, Japan.
authors.forename: Kinsei
authors.initials: K
authors.lastname: Anzai
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kono
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Mizoguchi
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Yanagi
authors.forename: Fumitoshi
authors.initials: F
authors.lastname: Hirayama
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Arima
authors.forename: Kaneto
authors.initials: K
authors.lastname: Uekama
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D001565:Benzoates / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D002236:Carbohydrate Conformation; D002247:Carbon Isotopes; D006146:Guanidines / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D016480:Helicobacter pylori / Q000187:drug effects; D006859:Hydrogen; D046911:Macromolecular Substances / Q000737:chemistry*; D019906:Nuclear Magnetic Resonance, Biomolecular; D014867:Water / Q000737:chemistry*; D047392:beta-Cyclodextrins / Q000737:chemistry* / Q000378:metabolism
chemical_list: C510407:4-methylbenzyl 4'-(4-(guanidinomethyl)cyclohexylcarbonyloxy)biphenyl-4-carboxylate; D000900:Anti-Bacterial Agents; D001565:Benzoates; D002247:Carbon Isotopes; D006146:Guanidines; D046911:Macromolecular Substances; D047392:beta-Cyclodextrins; D014867:Water; D006859:Hydrogen; C031215:betadex